LLDT-8 exerts its anti-osteoclastogenesis effect in RA probably through regulating RANKL/RANK/OPG system and its downstream signaling pathway as well as cytokine productions. The gene discussed is TNFRSF11A; the disease is rheumatoid arthritis.